Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Comparing robot-assisted and traditional laparoscopic surgery for endometriosis

Official title: Robot-Assisted Versus Standard Laparoscopic Approach of Total Hysterectomy for Deep Infiltrating Endometriosis and Adenomyosis: A Multicenter, Open-label Randomized Controlled Trial

Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT06445179 · Data updated 2026-11-12

This study is testing whether robot-assisted surgery is safer and more effective than traditional surgery for women with deep endometriosis who need a total hysterectomy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment224 (estimated)
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Academic / other
Locations2 sites (Aix-en-Provence and 1 other locations)
StatusRecruiting
StartedApril 16, 2025
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT06445179 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older diagnosed with deep infiltrating endometriosis and adenomyosis, without digestive tract involvement.

Probably not a fit

Patients with digestive tract involvement or those who only have adenomyosis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ENDO-RAS trial evaluates the safety and effectiveness of robot-assisted laparoscopy versus conventional laparoscopy for total hysterectomy in patients with deep infiltrating endometriosis and adenomyosis, without digestive tract involvement. Patients will be randomly assigned to one of the two surgical approaches after meeting specific eligibility criteria and providing informed consent. The study aims to reduce intraoperative and postoperative complications by utilizing advanced robotic technology in surgical procedures. This multicenter, randomized, controlled, and open-label study will utilize established classifications to assess the severity of endometriosis and predict potential complications.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing hysterectomy for endometriosis.

How similar studies have gone: Previous studies have shown promising results with robotic-assisted surgical techniques, suggesting potential benefits in similar surgical contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years of age.
* Diagnosed adenomyosis, either internal or external (magnetic resonance imaging) per the Enzian and dPEI classifications.
* Diagnosed deep infiltrating endometriosis per the Enzian and dPEI classifications, without the involvement of the digestive tract.
* Failure of first- and second-line medical treatment.
* Eligibility for total hysterectomy with complete removal of endometriosis lesions.
* Participants covered by entitled to social security.
* All participants must provide written informed consent before undergoing the surgical procedure.

Exclusion Criteria:

* Digestive tract involvement.
* Adenomyosis only.
* Contraindications to surgery.
* Participants who are under guardianship, curatorship, or deprivation of liberty.

Where it's running

  • Hôpital Privé de Provence
    Aix-en-Provence, France
    Recruiting
  • Hôpital Privé le Bois
    Lille, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.